Search Page
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 1992 | 1 |
| 1996 | 1 |
| 1999 | 2 |
| 2002 | 1 |
| 2004 | 4 |
| 2005 | 3 |
| 2006 | 3 |
| 2007 | 4 |
| 2008 | 3 |
| 2009 | 3 |
| 2010 | 9 |
| 2011 | 12 |
| 2012 | 6 |
| 2013 | 4 |
| 2014 | 6 |
| 2015 | 11 |
| 2016 | 4 |
| 2017 | 4 |
| 2018 | 9 |
| 2019 | 8 |
| 2020 | 12 |
| 2021 | 18 |
| 2022 | 4 |
| 2023 | 5 |
| 2024 | 9 |
| 2025 | 16 |
| 2026 | 7 |
Search Results
149 results
Results by year
IVST ranged from 12.1-14.9 mm at baseline and 10.8-14.1 mm at follow-up (all p < 0.05). LVPWT ranged from 11.7-16.0 mm at baseline and 10.7-13.0 mm at follow-up (all p < 0.05). Significant reductions in cardiac mass were demonstrated after 1 year of treatment
…IVST ranged from 12.1-14.9 mm at baseline and 10.8-14.1 mm at follow-up (all p < 0.05). LVPWT ranged from 11.7-16.0 mm at baseline
…By contrast, exercise-induced hyperemic MBF decreased significantly at normoxia (2.51 +/- 0.58 ml/min/g vs. 2.15 +/- 0.47 ml/min/g; p < 0.05) and hypoxia (5.15 +/- 0.79 ml/min/g vs. 3.98 +/- 0.83 ml/min/g; p < 0.005 vs. baseline; p < 0.005 vs. normox
…RESULTS: Aortic stiffness was approximately twofold higher in anabolic androgens user bodybuilders compared with drug-free bodybuilders [P < 0.001]. CONCLUSION: The present study demonstrates that chronic anabolic androgens use clearly produces significant decrease in t
…However, pre-LVH FD with normal T1 (n = 40/72, 56%) also had abnormalities compared to controls: reduced GLS (-18 2 vs. -20 2%, P < 0.001), microvascular changes (lower MBF 2.5 0.7 vs. 3.0 0.8 mL/g/min, P = 0.028), subtle T2 elevation (50 4 vs. 48 2 m
…